京都大学医学部附属病院 循環器内科

学会発表(国際学会) – 2000年

  1. Sasayama S: Inotropic therapy in chronic congestive heart failure. 9th International Congress on Cardiovascular Pharmacotherapy. March 27, Salvador, Bahia, Brazil.
  2. Sasayama S: Heart failure: transition from physiological adaptation to maladaptation. VI World Congress of the International Society for Adaptive Medicine. August 30-September 2, Lyon, France.
  3. Matsumori A: Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells. 9th International Congress on Cardiovascular Phamacotherapy, March 26-30, Bahia, Brazil.
  4. Miyamoto T, Hwang MH, Nishio R, Ito H, Matsumori A: Therapeutic effects of FTY 720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. The 73th Scientific Sessions of the American Heart Association. November 12-15, New Orleans, U.S.A.
  5. Kasuno K, Muso E, Ono T, Matsutani H, Nakamura H, Sasayama S, Yodoi J: Role of the Ioredoxin and Glutaredoxin in Renal Ischemia/Hypoxia. The 4th Tsurumai Seminer on Tubulointerstitial Injury. February 5, Nagoya, Japan.
  6. Ihara T, Muso E, Sasayama S, Ishida-Okawara A, Hashimoto Y, Suzuki K: Studies on Neutrophil Function and Glomerulonephritis. 9th International Vasculitis/ANCA Workshop. April 12-15, Gloningen, The Netherlamds.
  7. Muso E, Nogaki F, Miyawaki S, Sasayama S: Recessive Hedity and Correlation with Glomerular IgA Deposition of High Serum IgA Trait in High IgA Prone Inbred Mice(HIGA). ERA-EDTA Europian Renal Association 2000. September 17-20, Nice, France.
  8. Muso E: Epidemiology of renal diseases and high blood pressure among university students in Japan. Proceeding of the 5th Franco-Japanese symposium of nephrology 2000. September 22-24, Marseille, France.
  9. Watanabe H, Muso E, Ono T, Sasayama S, Uno K: LDL-apheresis (LDL-A) significantly recovered suppressed IFN-γproduction capacity (PC) of IL-12 stimulated peripheral blood in patients with nephrotic syndrome(NS). The American Society of Nephrology Official 2000. October 13-16, Tront, Canada.
  10. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Muso E, Sasayama S: Mesangial factor V expression and its relationship to mesangial proliferation in IgA nephropathy. The American Society of Nephrology Official 2000. October 13-16, Tront, Canada.
  11. Ono T, Liu N, Makino T, Kusano H, Muso E, Honda G, Sasayama S: Role of Factor V expression in crescents formation in rat experimental mesangioproliferative glomerulonephritis. The American Society of Nephrology Official 2000. October 13-16, Tront, Canada.
  12. Nogaki F, Kamata T, Fagarasan S, Miyawaki S, Ikuta K, Honjo T, Muso E, Sasayama S: Analysis of GALT and peritoneal B-1 cells in a murine model of IgA nephropathy, high serum IgA ddY mice (HIGA mice). The American Society of Nephrology Official 2000. October 13-16, Tront, Canada.
  13. Kobayashi I, Muso E, Kusano H, Nogaki F, Miyawaki S, Yoshida H, Sasayama S: IL-12 induces the chemicophysical change of serum and glomerular IgA in a high IgA strain of ddY (HIGA) mice.The American Society of Nephrology Official 2000. October 13-16, Tront, Canada.
  14. Liu N, Ono T, Kusano H, Suyama K, Nogaki F, Muso E, Sasayama S: The mechanisms of intramesangial coagulation in mesangioproliferative glomerulonephritis. Hong Kong Renal Association 2000. October 29, Hong Kong.
  15. Hosokawa R, Nohara R, Hirai T, Fujita M, Sasayama S : Is myocardial oxidative metabolism important for the risk stratification f the patients with heart failure?  The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function, February 24-26, Kyoto.
  16. Nohara R : Exercise benefit from prevention to management of ischemic heart disease. International Conference of Exercise and Nutrition for better Health and Chronic Disease. June 11-15, Beijing.
  17. Nohara R : Energetic and metabolic aspects of heart failure – Lipid and glucose metabolism -. 4th Annual Meeting of the Japanese Heart Failure Society. October 8-10, Kobe.
  18. Hosokawa R, Nohara R, Hirai T, Masuda D, Kataoka K, Tadamura E, Konishi J, Fujita M, Sasayama S : Can myocardial oxidative metabolism predict the cardiac events of the patients with heart failure? 4th Annual Meeting of the Japanese Heart Failure Society. October 8-10, Kobe.
  19. Hirai T, Nohara R, Hosokawa R, Masuda D, Kataoka K, Inada H, Chen L, Nakamura T, Tadamura E, Inubushi M, Kubo S : Different responses in heart and lung of 123I-MIBG metabolism to nasal continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  20. Hosokawa R, Nohara R, Hirai T, Inada H, Kataoka K, Masuda D, Tadamura E, Konishi J : Predictive values of cardiac metabolical imagings for the effectiveness of b-blocker therapy in patients with chronic heart failure-C-11 acetate versus I-123 MIBG. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  21. Kubota T, Shimizu W, Yoshida H, Otani H, Ogawa M, Kurita T, Yamashita F, Horie M, KamakuraS, Sasayama S: A novel missense mutation in S4-S5-linker of KCNQ1 underlies hypokalemia-induced acquired Long QT syndrome. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orelans.
  22. Horie M, Yosida H, Yamasita F, Kubota T, Otani H, Sasayama S: Molecular aspects of congenital long QT syndrome. 第17回国際心臓研究学会. December 6-8, 千里.
  23. Kihara Y: Modulation of Growth Signal Pathways During Heart Failure Transition. The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. Invited speaker, February 26, Kyoto, Japan.
  24. Izumi T, Kihara Y, Sasayama S: Source of trigger Ca2+ for CICR is switched from Ca2+ channels to Na+-Ca2+ exchangers during heart failure transition in hypertrophic rat ventricular myocytes. The 49th Annual Scientific Session, American College of Cardiology. March 12-15, Anaheim, USA.
  25. Izumi T, Kihara Y, Yoneda T, Iwanaga Y, Sasayama S: T-type calcium channel is induced by endothelin-1 but not by angiotensin II in adult rat ventricular myocytes.The 7th Antwerp-La Jolla-Kyoto research Conference on Cardiac Function. February 26, Kyoto.
  26. Sarai N, Kihara Y, Noma A, Izumi T, Mituiye T, Matsuoka S, Sasayama S: Novel method to measure real-time individual sarcomere length in single heart cells supports the local control theory. The 7th Antwerp-La Jolla-Kyoto research Conference on Cardiac Function. February 26, Kyoto.
  27. Sarai N, Kihara Y, Mitsuiye T, Matsyuoka S, Izumi T, Noma A: A group of Ca2+ sparks is mandatory to induce shortening of each sarcomere. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  28. Hayashida W, Kihara Y, Yasaka A, Sasayama S: Stage-specific differential activation of MAPK kinases in the hypertrophied and failing left ventricular myocardium. Cardiomyopathy 2000: The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto, Japan.
  29. Hayashida W, Kihara Y, Yasaka A, Sasayama S: Alterations of cardiac calcineurin/NFAT3 pathway during transition from hypertrophy to heart failure in rats. Cardiomyopathy 2000: The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto, Japan.
  30. Hayashida W, Kihara Y, Yasaka A, Sasayama S: Chronic endothelin receptor blockade improves cardiac troponin-T isoform shift and contractile dysfunction in rats with heart failure. Cardiomyopathy 2000: The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto, Japan.
  31. Hayashida W, Kihara Y, Inagaki K, Iwanaga Y, Yasaka A, Sasayama S: Chronic angiotensin converting enzyme inhibition restores the responsiveness of cardiac mitogen-activated protein kinase in rats with heart failure. American College of Cardiology 49th Annual Scientific Session. March 12-15, Anaheim, USA.
  32. Hasegawa K, Morimoto T, Kakita T, Kihara Y, Sasayama S: P300=GATA Transcriptional Pathway That Modulates Heart Failure. The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto.
  33. Morimoto T, Hasegawa K, Kakita T, Kihara Y, Sasayama S: A Nuclear Complex of GATA4/p300 in Rat Left Ventricular Myocardium Is Markedly Up-Regulated during the Transition from Compensated Hypertrophy to Heart Failure. The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto.
  34. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Sasayama S: Lisinopril Blocks Extracellularly Responsive Kinase-GATA-4 Pathway in Cardiac Myocytes. The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto.
  35. Iwai-Kanai E, Yanazume T, Fujita M, Sawamura T, Hasegawa K: Overexpression of Lox-1 Induces Myocardial Cell Apoptosis Via a P38 Mitogen-Activated Protein Kinase-Dependent Pathway. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  36. Morimoto T, Kakita T, Wada H, Hasegawa K: Acetylation of GATA-4 by P300 and PCAF is Involved in Endothelin-1 Transcription. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  37. Kakita T, Morimoto T, Yanazume T, Hasegawa K: Overexpression of P300 is Sufficient to Induce Cardiac Endothelin-1 Expression and Hypertrophy In Vivo. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  38. Wada H, Morimoto T, Kakita T, Hasegawa K: Calcineurin-GATA-6 Pathway is Involved in Smooth Muscle-Specific Transcription. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  39. Wada H, Morimoto T, Kakita T, Hasegawa K: Rho/ROCK Pathway is Required for the Activation of GATA-6 in Smooth Muscle-Specific Transcription. 2nd International Conference on GATA Transcription Factors. November 18-19, Tsukuba.
  40. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama S: Involvement of p300 in cAMP/PKA-mediated Cell Type-specific Apoptosis in Cardiac Myocytes. Keyston Symposia. January 12-17, Utah.
  41. Takimoto Y, Aoyama T, Keyamura R, Shinoda E, Hattori R, Yui Y, Sasayama S: Differential Expression Of Three Types Of Nitric Oxide Synthetase In Both Infarcted And Non-infarcted Left Ventricles After Myocardial Infarction In The Rat. The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto.
  42. Takimoto Y, Aoyama T, Keyamura R, Yui Y: Activated-TGF b1-TAK pathway in cardiomypcytes in non-infarcted region and its relation to ventricular remodeling after myocardial infarction in rats. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans.
  43. Shioji K, Kishimoto C, Nakamura H, Toyokuni Y, Nakayama Y, Yodoi J, Sasayama S: Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. 10th Biennial Meeting of the International Society for Free Radical Research (SFRR 2000). October 16-20, Kyoto.
  44. Nakayama Y, Kishimoto C, Shioji K, Sasayama S: Therapy with immunoglobulin ameliorates giant cell myocarditis in rats. 10th Biennial Meeting of the International Society for Free Radical Research (SFRR 2000). October 16-20, Kyoto.
  45. Yasaka A, Hayashida W, Kihara Y, Inagaki K, Sasayama S: Activation of JAK/STAT pathway by hemodynamic load in the normal and hypertrophied left ventricular myocardium. Cardiomyopathy 2000: The 7th Antwerp-La Jolla-Kyoto Research Conference on Cardiac Function. February 24-26, Kyoto, Japan.
  46. Yasaka A, Hayashida W, Kihara Y, Inagaki K, Iwanaga Y, Yasaka A, Sasayama S: Stretch-induced activation of cardiac Jak/STAT pathway is augmented in the rat hypertensive hearts: Role of endogenous angiotensin II. American College of Cardiology 49th Annual Scientific Session. March 12-15, Anaheim, USA.
  47. Yasaka A, Hayashida W, Kihara Y, Sasayama S: Differential activation of MAP kinases in the hypertrophied and failing rat left ventricular myocardium. XXII Congress of the European Society of Cardiology. August 26-30, Amsterdam, The Netherlands.
  48. Yasaka A, Hayashida W, Kihara Y, Sasayama S: Activation of JAK/STAT pathway by haemodynamic load in the normal and hypertrophied rat left ventricular myocardium.XXII Congress of the European Society of Cardiology. August 26-30, Amsterdam, The Netherlands.
  49. Hayashida W, Yasaka A, Kihara Y: Chronic endothelin receptor blockade improves cardiac troponin-T isoform shift and left ventricular contraction in rats with heart failure. The 73rd Scientific Sessions of American Heart Association. November 12-15, New Orleans, USA.
  50. Miyamoto S, Fujita M, Yamazaki S, Sekiguchi H, Eiho S, Yamamoto Y, Tamaki S, Hiki K, Nohara R, Nakayama Y, Okano Y, Ichiyama S: Effects of patient’s posture on cardiac autonomic nervous activity in patients with congestive heart failure. The 49th Annual Scientific Session of the American College of Cardiology. March 12-15, Anaheim.
  51. Araki M, Hasegawa K, Iwai-Kanai E, Fujita M, Kakita T, Morimoto T, Sasayama S: Basic fibroblast growth factor inhibits lipopolysaccharide-induced apoptosis in cardiac myocytes. The 49th Annual Scientific Session of the American College of Cardiology. March 12-15, Anaheim.
  52. Fujita M: Heparin and angiogenic therapy. The 6th Proteoglycan Forum. June 24, Hamamatsu.
  53. Fujita M: Clinical significance of coronary collateral circulation. 5HT Conference. July 6-7, Beijing.
  54. Fujita M, Masuda D, Nohara R, Sasayama S: Enhanced external counterpulsation with heparin pretreatment improves exercise capacity of anginal patients. The 3rd International Congress on Coronary Artery Disease. October 2-5, Lyon.
  55. Kinugawa T, Fujita M, Lee J-D, Nakajima H, Hanada H: Sarpogrelate, a serotonin blocker, for the treatment of effort angina: results of recent clinical trials. The 3rd International Congress on Coronary Artery Disease. October 2-5, Lyon.
Scroll